The global extracorporeal membrane oxygenation machine market was valued at USD 541 million in 2021 and it is anticipated to grow further up to USD 862 million by 2031, at a CAGR of 4.8% during the forecast period.
Global extracorporeal membrane oxygenation machine report from Global Insight Services is the single authoritative source of intelligence on extracorporeal membrane oxygenation machine market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10285
Key Players
- FRESENIUS MEDICAL CARE AG & CO. KGAA
- GETINGE GROUP
- MEDTRONIC PLC
- MICROPORT
- TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
- NIPRO CORPORATION
- LIVANOVA PLC
- EUROSETS S.R.L.
- ORIGEN BIOMEDICAL, INC
Global Extracorporeal Membrane Oxygenation Machine Market Segmentation
By Component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
By Modality
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS10285
Market Trends and Drivers
The increasing adoption of ECMO in lung transplantation procedures is boosting the growth of the market. In recent years, there has been a surge in lung transplantation, particularly for the treatment of advanced lung conditions such as cystic fibrosis, interstitial lung disease, and chronic obstructive pulmonary disease (COPD). The use of ECMO equipment in lung transplant operations has grown dramatically over time in the treatment of patients with advanced lung disease. Primary Graft Dysfunction (PGD) following lung transplantation is the most typical reason for using ECMO. PGD is a syndrome that develops within the first 72 hours of a lung transplant. Numerous studies have demonstrated promising results in relation to the use of ECMO as a bridging approach as well as therapy for individuals suffering from PGD after transplant thanks to substantial technological advancements. In the upcoming years, it is anticipated that ECMO use would increase even more due to the rising prevalence of lung illnesses worldwide.
For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/inquiry-before-buying/GIS10285
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700